| Confirmed speakers |
| Adriaan Fruijtier CATS Consultants, Dietmannsried, Germany | |
| Udai Banerji The Institute of Cancer Research, London, United Kingdom | |
| Rob Berg INC Research, Amsterdam, The Netherlands | |
| Lucinda Billingham Institute of Cancer and Genomic Sciences, Birmingham, United Kingdom | |
| Christian Blank Netherlands Cancer Institute, Amsterdam The Netherlands | |
| Ferry Eskens Erasmus MC, Rotterdam, The Netherlands | |
| Eric Hoedemaker Novartis, The Netherlands | |
| Michel Janicot JMI ONConsulting, Brussels, Belgium | |
| Jos Jonkers The Netherlands Cancer Institute, Amsterdam, The Netherlands | |
| Martina Kaufmann Martina Kaufmann Strategic Consulting, Muellheim, Germany | |
| Marie José Kersten Hematologist, Academic Medical Center, Amsterdam, The Netherlands | |
| Marinus Lobbezoo Congress by design, Harmelen, The Netherlands | |
| Benno Rattel Amgen, Munich, Germany | |
| Eric van der Putten Aglaia Biomedical Ventures, Bilthoven, The Netherlands | |
| Paul van Diest University Medical Center, Utrecht, The Netherlands | |
| Alain van Gool Radboud University Medical Center, Nijmegen, The Netherlands | |
| Jan Vermorken Antwerp University Hospital, Edegem, Belgium | |
